Bank of New York Mellon’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Buy
238,507
+37,695
+19% +$218K ﹤0.01% 2926
2025
Q1
$1.33M Sell
200,812
-2,129
-1% -$14.1K ﹤0.01% 2883
2024
Q4
$1.77M Sell
202,941
-2,737
-1% -$23.8K ﹤0.01% 2799
2024
Q3
$4.02M Sell
205,678
-50,219
-20% -$981K ﹤0.01% 2398
2024
Q2
$5.27M Buy
255,897
+11,212
+5% +$231K ﹤0.01% 2325
2024
Q1
$5.22M Sell
244,685
-16,104
-6% -$343K ﹤0.01% 2308
2023
Q4
$3.75M Sell
260,789
-955
-0.4% -$13.7K ﹤0.01% 2512
2023
Q3
$2.39M Buy
261,744
+25,677
+11% +$234K ﹤0.01% 2707
2023
Q2
$2.5M Buy
236,067
+10,516
+5% +$111K ﹤0.01% 2714
2023
Q1
$2.76M Sell
225,551
-5,114
-2% -$62.5K ﹤0.01% 2615
2022
Q4
$2.86M Buy
230,665
+2,004
+0.9% +$24.9K ﹤0.01% 2649
2022
Q3
$3.12M Buy
228,661
+21,821
+11% +$298K ﹤0.01% 2560
2022
Q2
$3.79M Sell
206,840
-24,813
-11% -$455K ﹤0.01% 2468
2022
Q1
$3.72M Buy
231,653
+812
+0.4% +$13.1K ﹤0.01% 2575
2021
Q4
$3.23M Sell
230,841
-24,230
-9% -$339K ﹤0.01% 2702
2021
Q3
$4.78M Buy
255,071
+36,351
+17% +$681K ﹤0.01% 2509
2021
Q2
$4.56M Sell
218,720
-79,622
-27% -$1.66M ﹤0.01% 2539
2021
Q1
$8.43M Buy
298,342
+12,746
+4% +$360K ﹤0.01% 2187
2020
Q4
$9.33M Buy
285,596
+43,007
+18% +$1.4M ﹤0.01% 2042
2020
Q3
$7.43M Buy
242,589
+35,696
+17% +$1.09M ﹤0.01% 2009
2020
Q2
$3.37M Buy
206,893
+57,065
+38% +$930K ﹤0.01% 2410
2020
Q1
$1.49M Buy
149,828
+4,919
+3% +$49K ﹤0.01% 2702
2019
Q4
$1.99M Buy
144,909
+3,821
+3% +$52.6K ﹤0.01% 2819
2019
Q3
$2.14M Buy
141,088
+19,436
+16% +$295K ﹤0.01% 2721
2019
Q2
$2.4M Sell
121,652
-414
-0.3% -$8.15K ﹤0.01% 2711
2019
Q1
$2.03M Buy
122,066
+593
+0.5% +$9.84K ﹤0.01% 2770
2018
Q4
$1.71M Buy
121,473
+9,218
+8% +$129K ﹤0.01% 2806
2018
Q3
$1.97M Buy
112,255
+9,884
+10% +$173K ﹤0.01% 2838
2018
Q2
$1.86M Buy
102,371
+19,072
+23% +$347K ﹤0.01% 2885
2018
Q1
$1.56M Buy
83,299
+16,363
+24% +$307K ﹤0.01% 2951
2017
Q4
$1.02M Buy
66,936
+7,655
+13% +$117K ﹤0.01% 3226
2017
Q3
$886K Buy
59,281
+28,031
+90% +$419K ﹤0.01% 3294
2017
Q2
$291K Buy
+31,250
New +$291K ﹤0.01% 3827